| 000 | 02897cam a2200529Ki 4500 | ||
|---|---|---|---|
| 001 | 9780429341250 | ||
| 003 | FlBoTFG | ||
| 005 | 20220711212411.0 | ||
| 006 | m d | ||
| 007 | cr cnu---unuuu | ||
| 008 | 200222s2020 si o 000 0 eng d | ||
| 040 |
_aOCoLC-P _beng _cOCoLC-P |
||
| 020 |
_a9781000681413 _q(electronic bk.) |
||
| 020 |
_a1000681416 _q(electronic bk.) |
||
| 020 |
_a9780429341250 _q(electronic bk.) |
||
| 020 |
_a0429341253 _q(electronic bk.) |
||
| 020 |
_a9781000680874 _q(electronic bk. : PDF) |
||
| 020 |
_a1000680878 _q(electronic bk. : PDF) |
||
| 020 |
_a9781000681147 _q(electronic bk. : Mobipocket) |
||
| 020 |
_a1000681149 _q(electronic bk. : Mobipocket) |
||
| 035 | _a(OCoLC)1141511270 | ||
| 035 | _a(OCoLC-P)1141511270 | ||
| 050 | 4 | _aRC271.C5 | |
| 072 | 7 |
_aMED _x009000 _2bisacsh |
|
| 072 | 7 |
_aMED _x062000 _2bisacsh |
|
| 072 | 7 |
_aSCI _x010000 _2bisacsh |
|
| 072 | 7 |
_aTBN _2bicssc |
|
| 082 | 0 | 4 |
_a616.994061 _223 |
| 245 | 0 | 0 |
_aNanoparticle drug delivery systems for cancer treatment _h[electronic resource] / _cedited by Hala Gali-Muhtasib, Racha Chouaib. |
| 260 |
_aMilton : _bPan Stanford Publishing, _c2020. |
||
| 264 | 1 |
_aSingapore : _bJenny Stanford Publishing, _c2019. |
|
| 300 | _a1 online resource (342 p.) | ||
| 500 | _aDescription based upon print version of record. | ||
| 520 | _aIn recent years, nanoparticles--bionanomaterials with specific physicochemical properties--have gained a great deal of scientific interest owing to their unique structure. Nanoparticle-based drugs are now widely regarded as a safer, more precise, and more effective mode of cancer therapy, considering their ability to enhance drug bioavailability, improve site-specific drug delivery, and protect nontarget tissues from toxic therapeutic drugs. This book compiles and details cutting-edge research in nanomedicine from an interdisciplinary team of international cancer researchers who are currently revolutionizing drug delivery techniques through the development of nanomedicines and nanotheranostics. Edited by Hala Gali-Muhtasib and Racha Chouaib, two prominent cancer researchers, this book will appeal to anyone involved in nanotechnology, cancer therapy, or drug delivery research. | ||
| 588 | _aOCLC-licensed vendor bibliographic record. | ||
| 650 | 0 |
_aCancer _xChemotherapy. _916205 |
|
| 650 | 0 |
_aDrug delivery systems. _97290 |
|
| 650 | 0 |
_aNanomedicine. _95252 |
|
| 650 | 7 |
_aMEDICAL / Biotechnology _2bisacsh _916206 |
|
| 650 | 7 |
_aMEDICAL / Oncology _2bisacsh _916207 |
|
| 650 | 7 |
_aSCIENCE / Biotechnology _2bisacsh _916208 |
|
| 700 | 1 |
_aGali-Muhtasib, Hala, _eeditor. _916209 |
|
| 700 | 1 |
_aChouaib, Racha, _eeditor. _916210 |
|
| 856 | 4 | 0 |
_3Taylor & Francis _uhttps://www.taylorfrancis.com/books/9780429341250 |
| 856 | 4 | 2 |
_3OCLC metadata license agreement _uhttp://www.oclc.org/content/dam/oclc/forms/terms/vbrl-201703.pdf |
| 942 | _cEBK | ||
| 999 |
_c71208 _d71208 |
||